Abstract
Background: Epithelium-derived cytokines such as thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33 are important contributors to inflammation in asthma. Exhaled breath condensate (EBC) is a noninvasive method used to assess the inflammation of airways. Our aim was to assess the levels of TSLP, IL-25, IL-33, and its receptor ST2l/IL-1 R4 in EBC in patients with asthma and to correlate these with serum levels and asthma control. Methods: EBC and serum levels of TSLP, IL-25, IL-33, and ST2l/IL-1 R4 were measured in 44 patients with chronic bronchial asthma (14 in the uncontrolled phase) and 19 healthy control participants. Results: EBC levels of IL-33 and TSLP and serum levels of IL-33 were statistically higher in patients with asthma than in controls. IL-25 and ST2l/IL-1 R4 were present in EBC at barely detectable levels and were not analyzed. The EBC and serum levels of all studied mediators did not differ between controlled and uncontrolled asthma patients, except for the serum level of ST2l/IL-1 R4, which was higher in uncontrolled asthma. There were no correlations between serum and EBC levels of TSLP and IL-33 or between either serum and EBC levels and the forced expiratory volume in 1 s or the total IgE level. Conclusions: Higher levels of IL-33 and TSLP in EBC provide evidence supporting a role for these mediators in asthma. Their levels do not discriminate between controlled and uncontrolled asthma. The local reaction within the epithelium is independent of the systemic reaction.
Journal Section:
Editor's choice
References
1.
Lloyd CM, Saglani S: Asthma and allergy: the emerging epithelium. Nat Med 2010;16:273-274.
[PubMed]
2.
Loxham M, Davies DE, Blume C: Epithelial function and dysfunction in asthma. Clin Exp Allergy 2014;44:1299-1313.
[PubMed]
3.
Koppelman GH, Meyers DA, Howard TD, et al: Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 2009;180:929-935.
[PubMed]
4.
Watson B, Gauvreau GM: Thymic stromal lymphopoietin: a central regulator of allergic asthma. Expert Opin Ther Targets 2014;18:771-785.
[PubMed]
5.
Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T, Naito T, Hirota T, Tamari M, Konno S, Nishimura M, Noguchi E, Hizawa Nl: A distinct sensitization pattern associated with asthma and the thymic stromal lymphopoietin (TSLP) genotype. Allergol Int 2013;62:123-130.
[PubMed]
6.
Birben E, Sahiner UM, Karaaslan C, Yavuz TS, Cosgun E, Kalayci O, Sackesen C: The genetic variants of thymic stromal lymphopoietin protein in children with asthma and allergic rhinitis. Int Arch Allergy Immunol 2014;163:185-192.
[PubMed]
7.
Xu D, Chan WL, Leung BP, Huang Fp, Wheeler R, Piedrafita D, Robinson JH, Liew FY: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787-794.
[PubMed]
8.
Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T: The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 2011;42:218-228
[PubMed]
9.
Milovanovic M, Volarevic V, Radosavljevic I, Pejnovic N, Arsenijevic N, Lukic ML: IL-33/ST2 axis in inflammation and immunopathology. Immunol Res 2012;52:89-99.
[PubMed]
10.
Glück J, Rymarczyk B, Rogala B: Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflamm Res 2012;5:547-550.
[PubMed]
11.
Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugiyama Y: Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164:277-281.
[PubMed]
12.
Ali M, Zhang G, Thomas WR, McLean CJ, Bizzintino JA, Laing IA, Martin AC, Goldblatt J, Le Souëf PN, Hayden CM: Investigations into the role of ST2 in acute asthma in children. Tissue Antigens 2009;73:206-212.
[PubMed]
13.
Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010;125;752-754.
[PubMed]
14.
Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, Martin JG, Hamid Q: Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009;183:5094-5103.
[PubMed]
15.
Cheng D, Xue Z, Yi L, Shi H, Zhang K, Huo X, Bonser LR, Zhao J, Xu Y, Erle DJ, Zhen Gl: Epithelial interleukin-25 is a key mediator in th2-high, corticosteroid-responsive asthma. Respir Crit Care Med 2014;190:639-648.
[PubMed]
16.
Munoz X, Bustamante V, Lopez-Campos J-L, Cruz M-J, Barreiro E: Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma. In Arch Allergy Immunol 2015;166:1-12.
[PubMed]
17.
Loukides S, Kontogianni K, Hillas G, Horvath I: Exhaled breath condensate in asthma: from bench to bedside. Curr Med Chem 2011;18:1432-1443.
[PubMed]
18.
Antczak A, Górski P: Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002;15:317-323.
[PubMed]
19.
Global Initiative for Asthma: Global strategy for asthma management and prevention. 2010. http://www.ginasthma.org/.
20.
Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E: ATS/ERS Task Force on exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-548.
[PubMed]
21.
Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 2005;26:319-338.
[PubMed]
22.
Dreborg S, Frew A: Position papers: allergen standardization and skin tests. Allergy 1993;48:9-82.
[PubMed]
23.
Cheng DT, Ma C, Niewoehner J, Dahl M, Tsai A, Zhang J, Gonsiorek W, Apparsundaram S, Pashine A, Ravindran P, Jung J, Hang J, Allard J, Bitter H, Tribouley C, Narula S, Wilson S, Fuentes MEDahl M, Tsai A, Zhang J, Gonsiorek W, Apparsundaram S, Pashine A, Ravindran P, Jung J, Hang J, Allard J, Bitter H, Tribouley C, Narula S, Wilson S, Fuentes ME: Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013;132:455-462.
[PubMed]
24.
Kim YH, Yang TY, Park C-S, Ahn SH, Son BK, Kim JH, Lim DH, Jang TY: Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 2012;49:738-743.
[PubMed]
25.
Togbe D, Fauconnier L, Madouri F, Marchiol T, Chenuet P, Rouxel N, Ledru A, Erard F, Quesniaux V, Ryffel B: Thymic stromal lymphopoietin enhances Th2/Th22 and reduces IL-17A in protease-allergen-induced airways inflammation. ISRN Allergy 2013;7:971036.
[PubMed]
26.
Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, Chen H: Neutralization of TSLP inhibit airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One 2013;8:e51268.
[PubMed]
27.
Verheijden KAT, Akbari P, Willemsen LE, Kraneveld AD, Folkerts G, Garssen J, Fink-Gremmels J, Braber S: Inflammation-induced expression of the alarmin interleukin 33 can be suppressed by galacto-oligosaccharides. Int Arch Allergy Immunol 2015;167:127-136.
[PubMed]
28.
Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR: Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 2014;370:2102-2110.
[PubMed]
29.
Bartemes KR, Kephart GM, Fox SJ, Kita H: Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 2014;134:671-678.
[PubMed]
30.
Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F: Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014;20:425-435.
[PubMed]
31.
Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Jerico Del-Rosario, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, Johnston SL: IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 2014;190:1373-1382.
[PubMed]
32.
Tomasiak-Łozowska MM, Zietkowski Z, Przeslaw K, Tomasiak M, Skiepko R, Bodzenta-Lukaszyk A: Inflammatory markers and acid-base equilibrium in exhaled breath condensate of stable and unstable asthma patients. Int Arch Allergy Immunol 2012;159:121-129.
[PubMed]
33.
Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Zietkowska E, Bodzenta-Lukaszyk A: Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010;11:110-119.
[PubMed]
34.
Hüttmann E-M, Greulich T, Hattesohl A, Schmid S, Noeske S, Herr C, John G, Jörres RA, Müller B, Vogelmeier C, Koczulla AR: Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS One 2011;11:e27467.
[PubMed]
© 2016 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2016
You do not currently have access to this content.
